Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 Apr 3;90(6):e202400754. doi: 10.1002/cplu.202400754

Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy

Davide Corinti 1,, Elisabetta Gabano 2, Barbara Chiavarino 1, Maria Elisa Crestoni 1, Domenico Osella 3, Simonetta Fornarini 1
PMCID: PMC12143457  PMID: 40099677

Abstract

Platinum(IV) complexes are being studied as potential alternatives to traditional platinum(II)‐based chemotherapy drugs. They promise reduced side effects and potential for oral administration. In fact, a preliminary reduction in the cellular medium is recognized as a crucial step for activation. However, a deeper understanding of the protonation sites and substitution behavior of Pt(IV) complexes is needed, considering that ligand hydrolysis may compete with reduction‐mediated activation, particularly in acidic environments such as the stomach. In this study, we investigated protonated Pt(IV) complexes with equatorial ligands common to widely used Pt(II) drugs containing square planar geometry, such as cisplatin and carboplatin. The additional axial substituents in the octahedral coordination sphere of Pt(IV) include different combinations of hydroxido and acetato ligands. Mass spectrometry‐based methods, including collision‐induced dissociation (CID) and infrared multiple photon dissociation (IRMPD) spectroscopy, supported by density functional theory (DFT) calculations, were employed. Structural characterization revealed that protonation preferences are influenced by the type and position of the ligands. Notably, protonation is generally favored on the carboxylato ligands; however, the carboplatin‐derived complex exhibited a mixed population of protomers, highlighting the significance of both axial and equatorial ligand configurations in shaping the prototropic equilibria happening in solution.

Keywords: Bioinorganic chemistry, Mass spectrometry, Density functional calculations, Anticancer agents


Protonated Pt(IV) complexes with various equatorial and axial ligands were characterized by IR ion spectroscopy and DFT. Protonation typically occurs at carboxylato ligands, eventually increasing their substitution propensity. However, the carboplatin‐derived complex showed mixed protomer populations, highlighting the significance of ligand selection to mitigate undesired reactivity.

graphic file with name CPLU-90-e202400754-g005.jpg

Introduction

Platinum is the exogenous element that has found the most prominent role in therapeutic applications. Platinum complexes are routinely used to treat various solid tumors, including lung, testicular, and ovarian cancers.[ 1 , 2 , 3 ] Currently, all FDA‐approved platinum‐containing drugs are square‐planar Pt(II) compounds with the general formula cis‐[PtX₂L₂], where X represents labile ligands prone to substitution reactions with nucleophiles, and L refers to inert ligands, typically nitrogen‐based nucleophiles such as ammonia or substituted amines. [4] Cisplatin (Scheme 1) is the simplest and most widely studied member of this family of platinating agents. It contains two chlorides and two ammonia groups in the coordination sphere of the metal. The chlorido ligands are readily substituted by water in cellular environments, giving rise to the diaqua complex of cisplatin (cis‐[Pt(NH3)2(OH2)2]2+), a positively charged species that is considered the active form of the drug.[ 5 , 6 ] This species interacts with the nucleobases of DNA producing inhibition of transcription and eventually cell‐death.[ 5 , 7 , 8 ] Despite their clinical utility, all approved platinum drugs exhibit significant adverse effects and are administered via slow intravenous infusion. This requirement reduces patient compliance and impacts quality of life. In contrast, platinum(IV) complexes offer features which enable their oral administration, thus overcoming some limitations associated with cisplatin treatment.[ 9 , 10 , 11 , 12 , 13 ] Pt(IV) complexes exhibit octahedral geometry and are more inert to ligand substitution. Thus, a preliminary reduction of the metal, involving the loss of the axial ligands, is required to activate the complex for its interaction with DNA.[ 10 , 14 , 15 , 16 ] The reduction and activation mechanisms of Pt(IV) antineoplastic complexes have been extensively studied, including computational analyses,[ 17 , 18 , 19 ] and experimental determinations of cellular reductants involved in these processes.[ 20 , 21 , 22 , 23 , 24 , 25 ] However, a universal consensus on the inert nature of Pt(IV) ligands is lacking.[ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 ] This is particularly relevant in acidic environments, such as the stomach, where ligand hydrolysis could occur, potentially altering the activation pathway. [27]

Scheme 1.

Scheme 1

Schematic representation of the assayed Pt(IV) complexes. The structures of cisplatin and carboplatin are also reported.

In order to gain knowledge on ligand susceptibility to substitution in acidic environments, we have explored the protonation sites of Pt(IV) complexes exhibiting diverse equatorial and axial ligands. Assayed species include 1 (cis,cis,trans‐[PtCl2(NH3)2(OH)2]), 2 (cis,cis,trans‐[PtCl2(NH3)2(OCOCH3)2]), 3 (cis,cis,trans‐[PtCl2(NH3)2(OCOCH3)(OH)]) and 4 (cis,cis,trans‐[Pt(C6H6O4)(NH3)2(OH)2]) (scheme 1). The first three complexes have a common equatorial scaffold and differ just for the axial ligands. In particular, the complexes 1, 2 and 3 have a cisplatin‐like structure with two ammonia and two chlorides in cis configuration as equatorial ligands, while in the axial positions 1 present two hydroxo groups, 2 two acetates, and 3 a mixed configuration with one acetato and one hydroxido ligand. In contrast, 4 replaces the equatorial chlorides with a 1,1‐cyclobutanedicarboxylato chelating ligand, the labile component of the antineoplastic drug carboplatin (scheme 1).

To structurally characterize the protonated complexes and generate information on the ligands that are more easily released in the gas phase, mass spectrometry‐based methods have been employed. This combined approach, consisting of collision‐induced dissociation (CID) experiments and IR multiple photon dissociation (IRMPD) spectroscopy backed by calculations at the DFT level,[ 38 , 39 , 40 , 41 , 42 ] has proven effective in obtaining structural information on different types of Pt complexes, relevant to both medicinal chemistry,[ 25 , 43 , 44 , 45 , 46 , 47 ] and catalysis.[ 48 , 49 , 50 ] Here, the protonation sites in the presence of diverse ligands were determined. The gathered information is intended to assist in the design of Pt(IV) complexes with an awareness of the potential for substitution in certain portions of the complex.

Experimental Section

Materials and MS Analysis

The investigated complexes, namely (OC‐6‐33)‐diamminedichloridodihydroxidoplatinum(IV) (oxoplatin, 1, cis,cis,trans‐[PtCl2(NH3)2(OH)2]), (OC‐6‐33)‐diacetatodiamminedichloridoplatinum(IV) (2, cis,cis,trans‐[PtCl2(NH3)2(OCOCH3)2]), (OC‐6‐44)‐acetatodiamminedichloridohydroxidoplatinum(IV) (3, cis,cis,trans‐[PtCl2(NH3)2(OCOCH3)(OH)]) and (OC‐6‐33)‐diammine(cyclobutane‐1,1‐dicarboxylato)dihydroxidoplatinum(IV) (4, cis,cis,trans‐[Pt(C6H6O4)(NH3)2(OH)2]) have been prepared as already described in literature.[ 51 , 52 , 53 , 54 , 55 ]

Samples were prepared by diluting the complexes in a water/methanol 50 : 50 v/v solution to a final concentration of 10−5 M. Formic acid was added to the solutions to increase protonation reaching a final concentration of 0.1 % v/v.

Mass spectrometry analyses were conducted using a Paul ion trap (Esquire 6000, Bruker) equipped with an electrospray ionization (ESI) source. Solutions were directly infused in the ESI source at a flow rate of 180 μL h−1. Parameters employed for the analyses were: capillary voltage at −3.8 kV, drying gas (N2) fluxed at 7 L/min at temperature of 300 °C, capillary exit at 60 V and skimmer voltage at 45 V. CID experiments have been performed on mass‐selected ions using an activation amplitude of 0.35 V and an activation time of 50 ms. Helium was employed as collision gas at a nominal pressure of 1.5×10−6 mbar.

Additional CID experiments were carried out using a linear ion trap mass spectrometer (LTQ XL, Thermo Scientific) coupled with an ESI source. Solutions were infused at a flow rate of 360 μL h−1. ESI parameters were set as follows: temperature at 250 °C, spray voltage at 5 kV, sheath gas flow rate at 10 arb. u., aux gas flow rate at 2 arb. u., capillary voltage at 20 V, and tube lens voltage at 50 V.

IRMPD Spectroscopy

IR multiple photon dissociation (IRMPD) spectra have been obtained in the X−H (X= C, N, O) stretching modes range (3000‐3700 cm−1), employing an optical parametric oscillator/amplifier (OPO/OPA) laser system (LaserVision) pumped by a 10‐Hz Nd:YAG laser which is allowed to interact with the ions trapped in the cell of a Paul ion‐trap (Bruker Esquire 6000) mass spectrometer. The apparatus has been already described in detail. [56] Mass‐selected ions were trapped for 10–40 ms, depending on their abundance, and irradiated for 1 to 3 s on the basis of their fragmentation yield. The OPO/OPA laser system generated an energy of ca. 15 mJ pulse−1 with a spectral width of 5 cm−1. The IR action spectra are obtained by plotting the photofragmentation yield R=− ln[Ip/(Ip + ΣIf)], where Ip and ΣIf are the parent and sum of the fragment ion abundancies, respectively, as a function of the radiation wavenumber. [57]

Computational Details

Guess structures of isomers of the protonated Pt‐containing complexes were optimized using the B3LYP functional and the 6–311+G(d,p) basis set for light atoms. For platinum the LanL2TZ basis set and ECP was used. All isomers were reoptimized with the double hybrid B2PLYP functional adding the D3 Grimme dispersion correction method, and the def2TZVP basis set for all atoms.[ 58 , 59 , 60 , 61 ] Harmonic IR spectra are presented scaled by a factor of 0.955,[ 43 , 45 , 46 , 47 , 61 , 62 ] in agreement with previous works on Pt‐complexes, and convoluted with a Gaussian profile considering a FWHM of 10 cm−1. All calculations were performed using Gaussian 16 rev.C01. [63]

Results and Discussion

Collision‐Induced Dissociation Experiments

The protonated complexes [1+H]+, [2+H]+, [3+H]+ and [4+H]+ were produced by ESI, and their isotopic clusters were mass selected in the cell of a quadrupole ion‐trap (Esquire 6000 plus, Bruker). The five main isotopic peaks were mass‐selected for the species containing Pt and Cl ([1+H]+ at m/z 333–337, [2+H]+ at m/z 417–421 and [3+H]+ at m/z 375–379), while 4 main isotopes are considered in [4+H]+ (m/z 405, 406, 407 and 409) due to the absence of any chlorine atom. When activated by CID, the whole set of protonated compounds primarly dissociates by the loss of a neutral molecule from the axial ligands. The resulting spectra are reported in Figure 1.

Figure 1.

Figure 1

Mass spectra obtained upon mass selection and collisional activation of A) [1+H]+, B) [2+H]+, C) [3+H]+ and D) [4+H]+. Formal neutral losses are reported. Insets show the calculated isotopic clusters of ions containing either Pt and two Cl atoms or the sole Pt atom. In the case of the fragment of [1+H]+ centered at m/z 299, the isotopic cluster indicates that it retains both chlorine atoms, confirming its attribution to [PtCl2N2H5]+. Below m/z 280 no fragments were observed or all species.

As shown in Figure 1, in the cases of the species presenting equal axial ligands, i. e. [1+H]+, [2+H]+ and [4+H]+, the main fragments correspond to the loss of either of these ligands as neutral species; specifically, elimination of H2O (product ion at m/z 315–319), acetic acid (m/z 357–361) and again water (m/z 387–391), respectively, followed by the loss of the remaining axial ligands. The consecutive nature of this process is confirmed by CID experiments performed employing a linear ion trap (LTQ‐XL), where consecutive fragmentation events are inhibited. Results are reported in Figure S1. In the specific case of [2+H]+, the prominent acetic acid dissociation channel is accompanied by ammonia loss (m/z 400–404), although showing minor intensity. Therefore, from the CID of the symmetric species, [1+H]+, [2+H]+ and [4+H]+, the dissociation of the axial ligand appears favored. This evidence is in agreement with previous studies on the unimolecular dissociation of satraplatin, trans,cis,cis‐diacetatoammine(cyclohexylamine)dichloridoplatinum(IV), the first Pt(IV) compound to have entered phase 3 of clinical trials, which show a predominant dissociation of the axial acetato ligand. [64] Additionally, the case of [2+H]+, whose fragmentation pattern involves ammonia loss in competition with acetic acid, suggests the acetate group to be more difficult to dissociate in the gas‐phase from platinum as compared to the water molecule. This line of reasoning is confirmed looking at the dissociation of the complex [3+H]+, which exhibits a mixed situation where the axial positions are occupied by either acetato or hydroxido ligands, as reported in Scheme 1. The CID spectrum of [3+H]+ (Figure 1 C) shows primary water loss (m/z 357–361) eventually followed by the cleavage of acetic acid at m/z 297–301. We could not find any evidence of a competing channel involving acetic acid loss directly from the parent ion (Figure S1) confirming the lower dissociation threshold of water compared to acetic acid from Pt(IV). It should be noted that in all the reported fragmentation pathways, the metal atom is not involved in any reduction process. This could be attributed to the ease with which the protonated axial ligands dissociate as neutral species, thereby avoiding redox reactions. In contrast, the same species in their deprotonated form, as well as non‐covalent complexes of Pt(IV) with ascorbate, exhibit a different behavior, generating reduced Pt species by activation in the gas‐phase, as reported in previous studies that explored the gas‐phase reactivity of these complexes.[ 25 , 65 , 66 ]

In the forthcoming section, the vibrational features of mass selected [1+H]+, [3+H]+ and [4+H]+ ions, will be discussed in comparison with theoretically calculated IR spectra in order to unveil their main structural characteristics. Notably, the IRMPD spectrum of [2+H]+ is not reported due to the absence of any significant fragmentation during the scan of the XH stretching range.

Vibrational and Structural Features of [1+H]+

In Figure 2, the IRMPD spectrum of [1+H]+ is reported and compared with the calculated IR spectra of 1 isomers at the B2PLYP level.

Figure 2.

Figure 2

IRMPD spectrum of [1+H]+ (green profile) compared to the theoretically calculated spectra of the 1_15 isomers at B2PLYP−D3 level. Geometries are reported on the left side together with Gibbs energies at 298 K in kJ mol−1. All calculated spectra are scaled by a factor of 0.955.

The isomers explored as potential structures of [1+H]+ are reported in Figure 2. They include three structures characterized by protonation on different ligands of the complex (1_13) and two ligand scrambled structures (1_4,5). 1_1, the lowest‐energy protomer of 1, retains the cisplatin equatorial structure and is protonated on the axial OH group, with the two hydrogens of the so formed water molecule oriented towards the chlorido ligands. 1_3, characterized by protonation on a chlorido ligand, is much higher in relative Gibbs energy, lying at 134 kJ mol−1. This energy difference aligns with the higher proton affinity of water compared to HCl (691.0 vs. 556.9 kJ mol−1, respectively). [67] Interestingly, an additional prototropic minimum energy structure have been identified, 1_2, featuring protonation on one axial OH ligand and a proton transfer from one ammonia molecule to the remaining OH, thus forming two water molecules bound axially to Pt. This structure is 103 kJ mol−1 higher in energy and contains one water molecule oriented toward the chlorido ligands, while the other interacts with the amino group. Structures 1_4 and 1_5 result from an exchanged position of ammonia and hydroxido ligands. The lowest energy species, 1_4, is protonated on the OH in trans to the chlorido, while 1_5 is protonated on the other OH ligand. However, ligand scrambling in octahedral Pt(IV) complexes has not been observed to date,[ 27 , 66 ] making such rearrangements unlikely under our experimental conditions.

The experimental vibrational features were compared to the calculated spectra of the reported isomeric structures (Figure 2). The sampled OH stretching range, from 3450 to 3600 cm−1, shows a complex cluster of bands indicative of the presence of multiple isomers. Interestingly, the best match is obtained by considering 1_1 and 1_2. Accordingly, the experimental IRMPD bands compared with the calculated vibrational modes of the two isomers are reported in Table 1. The convoluted band from 3450 to 3600 cm−1 can be assigned in part to the calculated OH stretching mode at 3577 cm−1, and to the asymmetric and symmetric stretchings of the water molecule at 3548 and 3478 cm−1, respectively, of 1_1. However, the main experimental IRMPD band at 3515 cm−1 aligns only with 1_2, where asymmetric stretches of water molecules interacting with the amino group or chlorido ligands occur at 3516 and 3506 cm−1, respectively. Four absorptions are recorded at lower wavenumber, namely at 3383, 3340, 3278 and 3240 cm−1, that are interpreted by the asymmetric and symmetric stretchings of the ammonia molecules, as reported in Table 1. The presence of 1_3 in the sampled ionic population is rather discarded in view of calculated vibrations above 3600 cm−1, where no activity is observed. Finally, while 1_4 and 1_5 could account for some spectral features, the absence of specific experimental bands (e. g., at 3515 cm−1) and the unlikelihood of ligand rearrangement rather dismiss their contribution. Moreover ligand scrambling was not observed when the same complex was spectroscopically analyzed as either deprotonated species or non‐covalently bound with ascorbate.[ 25 , 65 , 66 ] In summary, the IRMPD sampling of [1+H]+ supports the combined presence of 1_1 and 1_2. However, the relative contribution of these species cannot be determined because IRMPD signal intensities do not directly correlate with the extinction coefficients of vibrational modes, due to the non‐linear nature of the multiple photon absorption process.[ 57 , 68 , 69 ]

Table 1.

Experimental IRMPD bands of [1+H]+ and calculated vibrational modes of 1_1 and 1_2.

[1+H]+

Experimental IRMPDa

Calculated IR frequenciesa,b

Vibrational mode assignment

1_1

1_2

3577

3573 (108)

OH stretching

3555

3548 (134)

H2O asymm stretching

3515

3516 (173)

H…OH asymm stretching

3506 (179)

H2O asymm stretching

3478

3474 (101)

H2O symm stretching

3383

3383 (113)

3378 (58)

NH3 asymm stretching

3340

3339 (92)

3350 (95)

NH3 asymm stretching

3338 (34)

NH3 asymm stretching

3342 (96)

H2O symm stretching

3278

3295 (38)

NH2 symm stretching

3240

3246 (33)

3250 (57)

NH3 symm stretching

3245 (61)

NH3 symm stretching

2807 (172)

H…OH symm stretching

a in cm−1. b Intensities are reported in brackets in km mol−1.

The presence of 1_2 is particularly intriguing. High‐energy isomers are typically observed in the gas‐phase population of ESI‐generated ions when they are predominantly formed in solution and cannot interconvert in the gas phase due to high transition‐state (TS) energies for conversion.[ 70 , 71 , 72 ] However, the TS located at 100.1 kJ mol−1 for the proton transfer from 1_2 to 1_1, shows a lower Gibbs energy than 1_2, thus indicating a loose transition state (Figure S2). Contrary to previous assumptions, this evidence suggests that proton transfer should occur readily in the gas‐phase as a barrierless process from 1_2 to 1_1. Therefore, the presence of 1_2 cannot result from kinetic trapping of this isomer during the ionization process.

Another notable observation concerns the IRMPD mass spectrum in the entire range, which almost exclusively shows a signal corresponding to the simultaneous loss of both water molecules (Figure S3). This outcome contrasts with the CID spectrum, where the first water loss is evident and predominant, accounting for approximately 50 % of the precursor‘s dissociation compared to the loss of the second water molecule (Figure 1). This discrepancy is unexpected, because the IRMPD process generally behaves similarly to CID in terms of ion energy distribution. Here, however, the IRMPD results and the identified spectroscopic features suggest that the presence of bands related to 1_2 may be linked to preliminary vibrational activation of 1_1 by the initial photons absorbed. This activation could transiently populate the higher‐energy isomer (1_2), which then readily undergoes dissociation, primarily resulting in the simultaneous loss of both water molecules.

IRMPD Spectroscopy of [3+H]+

Figure 3 displays the IRMPD spectrum of [3+H]+ compared to IR spectra of calculated isomers exhibiting protonation on either the acetato (3_1) or hydroxido (3_2) ligands. Additionally, a structure with both the acetato and hydroxido ligands protonated was also considered, namely 3_3, as suggested by previous evidence gathered about [1+H]+. 3_1 is the lowest lying isomer and presents a H‐bond involving the OH of the protonated acetato ligand and a chlorine atom. 3_2 represents instead the isomer characterized by protonation on the hydroxido ligand. This isomer shows the CO group of the acetate group directed towards the ammonia ligands and is placed at a relative Gibbs energy of 22.8 kJ mol−1. Higher‐energy conformers with protonation on the acetato ligand (3_4 and 3_5) and an isomer with the chlorine atom protonated (3_6) have also been considered and are reported in Figure S4. In particular, the structure 3_4, lying at 19.8 kJ mol−1, shows a non‐covalent interaction of a methyl hydrogen with a chlorido ligand, and the carboxylic acid moiety in cis conformation, while at 35.9 kJ mol−1 the 3_5 conformer has the carboxylic function in trans conformation with the oxygen oriented toward one of the hydrogens of the ammonia molecule. Isomer 3_6 is the higher in relative energy (118.9 kJ mol−1) and show the added proton oriented toward the oxigen of the acetato bound to Pt.

Figure 3.

Figure 3

IRMPD spectrum of [3+H]+ (blue profile) compared to the theoretically calculated spectra of the structures 3_1, 3_2 and 3_3 at the B2PLYP−D3 level scaled by a factor of 0.955. Geometries are shown on the left together with relative Gibbs energies at 298 K in kJ mol−1.

The IR spectrum of 3_1 in Figure 3 accounts for all major absorptions. Notably, it shows a single vibrational mode in the high‐frequency region of the spectrum corresponding to the OH stretching calculated at 3578 cm−1. This vibration matches well with the experimental band at 3579 cm−1. In contrast, 3_3 features only one vibrational mode in the high‐frequency region, namely the asymmetric H₂O stretching calculated at 3531 cm−1, which does not align with the experimental feature. In the range below 3450 cm−1, which is characterized by NH and CH stretching modes, three major bands can be highlighted at 3387, 3346 and 3286 cm−1, which are assigned to the ammonia asymmetric and symmetric stretchings calculated for 3_1 at 3388, 3348, 3341 and 3251, 3248 cm−1, respectively. Additionally, the broad absorption with maximum at 3239 cm−1 shows consistency with the OH stretching mode of the carboxilic acid calculated at 3240 cm−1. This assignment is consistent with the fact that the H atom is engaged in a H‐bond with the chlorido ligand. In fact, such vibrational motifs, particularly stretching motions involving hydrogen‐bonded atoms, tend to produce broadened IRMPD bands. This broadening arises from the asymmetric nature of the vibration, which disrupts the multiple‐photon absorption process.[ 68 , 69 , 73 , 74 ] The experimental bands and calculated vibrational modes for the two selected isomers 3_1 and 3_2 are reported in Table 2. It is evident that 3_2 does not significantly contribute to the sampled gas‐phase population. This conclusion is supported by the calculated wavenumbers of its characteristic asymmetric and symmetric H₂O stretching modes at 3505 and 3437 cm−1, which fall in a region of the spectrum devoid of significant experimental absorptions.

Table 2.

Experimental IRMPD bands of [3+H]+ and calculated vibrational modes of 3_1 and 3_2.

[3+H]+

Experimental IRMPDa

Calculated IR frequenciesa,b

Vibrational mode assignment

3_1

3_2

3579

3578 (114)

OH stretching

3505 (142)

H2O asymm stretching

3437 (130)

H2O symm stretching

3387

3388 (82)

3374 (126)

NH3 asymm stretching

3346

3348 (61)

3319 (79)

NH3 asymm stretching

3341 (60)

3317 (114)

NH3 asymm stretching

3286

3251 (51)

NH3 symm stretching

3248 (85)

NH3 symm stretching

3239

3240 (429)

3204 (171)

CO−H stretching

a in cm−1. b Intensities are reported in brackets in km mol−1.

IRMPD Spectroscopy of [4+H]+

Complex 4 contains two axial hydroxido ligands and a cyclobutane‐1,1‐dicarboxylate chelating ligand in equatorial position, together with two ammonia molecules. Two conceivable protonation sites can involve the axial hydroxido ligand or the carboxylate moiety of the chelating ligand. Figure 4 illustrates the optimized geometries of selected calculated isomers along with their theoretical IR spectra, together with the experimental IRMPD spectrum. The most stable structures, 4_1 and 4_2, are both protonated on one or the other carboxylate oxygen atoms not bound to Pt, in agreement with the ascribed structure of protonated carboplatin. [43] In both cases, the proton is oriented toward the other oxygen of the same carboxylate group in a cis‐like configuration. Protonation on the latter oxygen results in an isomer, 4_6, which lies 64.5 kJ mol−1 higher in energy relative to 4_1. This energy gap is consistent with the increased acidity of the COH group due to the umpolung effect induced by its binding to platinum. The structures of 4_3 and 4_4 are both protonated on the axial OH, but differ in the positioning of the carboxylate groups of the cyclobutane‐1,1‐dicarboxylate ligand relative to the protonation site. Notably, 4_3 presents a lower energy than 4_4, lying at 9.2 kJ mol−1, and exhibits a quasi‐planar geometry for the five‐membered ring formed by the carboxylato groups and the platinum atom. In this structure, the protonated hydroxo ligand and the cyclobutyl group occupy opposite sides relative to the plane defined by the five‐membered ring. Conversely, 4_4 shows a H‐bond interaction involving the H‐atom of the aqua ligand and the carboxylate oxygen (Figure 4). Despite this additional intramolecular interaction, the structure is higher in energy, lying at 16.4 kJ mol−1. The reduced stability likely arises from the steric strain imposed on the cyclobutane‐1,1‐dicarboxylate ligand by the H‐bond interaction. Finally, 4_5 (30.6 kJ mol−1) explores the possibility of a proton transfer from the ammonia molecule to water starting from the global minimum 4_1.

Figure 4.

Figure 4

IRMPD spectrum of [4+H]+ (red and grey profiles) compared to the theoretically calculated spectra of the structures 4_16 at the B2PLYP−D3 level scaled by a factor of 0.955. Geometries are shown on the left together with relative Gibbs energies at 298 K in kJ mol−1.

The spectroscopic evidence aligns with the computed relative energies, showing a fair agreement between the IRMPD spectrum and the calculated spectra of the lowest energy isomers protonated on either the carboxylato ligands (4_1 and 4_2) or the hydroxido ligand (4_3). The experimental features together with the calculated ones for the selected structures are reported in Table 3. Of particular interest is the range of the OH stretching modes at 3500–3650 cm−1, which shows three experimental bands, suggesting the presence of a mixed population. The intense IRMPD band at 3569 cm−1 is well simulated by OH stretching modes of the hydroxido and aqua ligands, calculated for 4_3 at 3580 and 3567 cm−1, respectively. The absorptions corresponding to the axial OH stretching modes of 4_1 and 4_2 predicted at 3630 and 3613, and at 3596 and 3600 cm−1, respectively, could account for the experimental band at 3586 cm−1. Additionally, the COH stretching mode of 4_1 and 4_2, calculated at ca. 3527 cm−1, accounts for the experimental band observed at 3545 cm−1. 4_3 also exhibits a vibration at 3483 cm−1 that could explain the 3463 cm−1 experimental band, although this mode shows limited IRMPD activity.[ 75 , 76 ] Absorptions in the spectral range below 3400 cm−1 can be attributed to a combination of the NH stretchings of the ammonia molecules, calculated in this range for the representative isomers 4_1, 4_2 and 4_3.

Table 3.

Experimental IRMPD bands of [4+H]+ and calculated vibrational modes of 4_1, 4_2 and 4_3.

[4+H]+

Experimental IRMPD

Calculated IR frequencies

Vibrational mode assignement

4_1

4_2

4_3

3586

3630 (40)

3613 (33)

OH stretching

3596 (60)

3600 (67)

3580 (133)

OH stretching

3569

3567 (127)

H2O asymm stretching

3545 (shoulder)

3528 (178)

3526 (173)

CO−H stretching

3463

3483 (94)

H2O symm stretching

3397

3382 (72)

3381 (73)

3387 (122)

NH3 asymm stretching

3370 (66)

3371 (64)

NH3 asymm stretching

3369 (43)

3370 (43)

NH3 asymm stretching

3339

3332 (72)

3345 (74)

3340 (77)

NH3 asymm stretching

3338 (45)

NH3 asymm stretching

3281

3267 (49)

3268 (49)

3250 (40)

NH3 symm stretching

3237 (39)

3237 (40)

3247 (48)

NH3 symm stretching

a in cm−1. b Intensities are reported in brackets in km mol−1.

Spectroscopically, 4_4 and 4_5 could participate to the gas‐phase population, albeit as minor components. It is worth noting that the OH stretching mode calculated for 4_4 at ~3100 cm−1, associated with the H‐bonded hydroxido group, could be IRMPD transparent possibly due to the disruption of the H‐bond network produced by the first photon absorption.[ 69 , 75 , 76 ] Finally, the spectrum of 4_6 does not match the experiment, and any significant presence of this isomer can be excluded.

To summarize, the assayed gas‐phase population mainly consists of 4_3, 4_1 and 4_2, with a slight predominance of the isomer protonated on the hydroxido ligand (4_3). The reported attributions are also confirmed by comparison of the calculated and experimental IR spectra in the fingerprint region, recorded for [4+H]+ to aid in solving the complexity of its ionic population and reported in Figure S5.

Discussion

IRMPD spectroscopy has allowed to characterize the protonated complexes of 1, 3 and 4, ionic species formed in solution and brought to the gas‐phase using an ESI source. [1+H]+ displays protonation on the hydroxido axial ligand, in agreement with its fragmentation behavior which involves a facile cleavage of water. Additionally, its IRMPD spectrum reveals the presence of a high energy species with two aqua ligand in the axial positions and one of the ammonia molecules turned into an amido ligand, NH2. Interestingly, the presence of this species appears to be enhanced during the IRMPD process considering the different fragmentation pattern of CID compared to IRMPD. In fact, a consecutive loss of two water molecules is observed under CID while the concurrent departure of both water molecules occurs in the process of IRMPD. The energetic of the process has been investigated by calculations at the B3LYP/6‐311+G(d,p) (Pt=LanL2TZ) level. Two possible scenarios were considered: 1) direct cleavage of water from 1_1 followed by proton transfer from ammonia to the remaining hydroxido ligand and finally dissociation of the second water molecule; 2) sequential cleavage of both water molecules from 1_2. Figure 5 reports the potential energy surfaces (PESs) for the two processes.

Figure 5.

Figure 5

PESs for the water dissociation reaction from 1_1 (blue profile) and 1_2 (green profile). Optimized structures at the B3LYP level are shown together with relative Gibbs energies at 298 K in kJ mol−1.

The direct cleavage of water from 1_1 (blue profile in Figure 5) is calculated to require 80.8 kJ mol−1. This process is thermodynamically favored compared to the dissociation of ammonia, which requires 143.3 kJ mol−1 at the same level of theory (Figure S6). The product of the water loss (1_1‐w) must overcome an energetically demanding proton transfer from one of the ammonia molecules to the hydroxido ligand (1_1−w_TS, lying at 221.5 kJ mol−1) to enable the dissociation of the second water molecule  (1−2 w). The calculated energetics for this fragmentation pathway are in line with the CID results (Figure 1 and Figure S1), where only one water molecule is preferentially dissociated. On the other hand, when submitted to IR photoactivation, the gas‐phase population was found to consist of both 1_1 and 1_2, a higher‐energy isomer with a Gibbs energy of 99.6 kJ mol−1 at the B3LYP level of theory. This species contains two water molecules, with one of the ammonia molecules already deprotonated  (Figure 2). The green profile in Figure 5 shows that the dissociation of the first neutral water is more energy‐demanding than that from 1_1, due to the presence of a transition state lying at 168.6 kJ mol−1 (1_2_TS), where H2O begins to depart from the complex while a chlorido ligand takes its place. The following dissociation of the second molecule of water requires only 130.8 kJ mol−1, thus making this dissociation pathways to reach dissociation of both water molecules collectively less energetically demanding than the one starting from 1_1. This simulated unimolecular reactivity agrees with the experimental observations, eventually explaining why the IRMPD process, in which the population of 1_2 is significant, produces a much lower yield of single water loss compared to the loss of both water molecules (Figure S3).

Calculations at the B3LYP level were employed to characterize also the unimolecular reactivity of [2+H]+. In particular, the goal was to evaluate why the dissociation of the ammonia molecule was observed exclusively for this complex. As shown in Figure S7, the energy required for the dissociation of acetic acid from the protonated complex 2_1 (119.1 kJ mol−1) is comparable to the lowest energy needed for the loss of ammonia, corresponding to a transition state located at 121.9 kJ mol−1. Direct dissociation of ammonia, leading to a pentacoordinated Pt(IV) complex, is energetically more demanding (156.5 kJ mol−1). However, the acetato ligand is able to chelate platinum, forming a more stable structure (2_1‐NH32) at 79.3 kJ mol−1 after overcoming the aforementioned TS. These calculations clearly explain why the dissociation of the ammonia molecule is observed specifically for the protonated complex 2.

Regarding protonated complex 3, its spectroscopic characterization appears to be more straightforward, unveiling a gas‐phase population mostly composed of the lowest lying calculated structure (3_1), which exhibits protonation on the acetate moiety. Interestingly, the IRMPD mass spectra in the whole IR range explored show a dissociation pattern involving only water loss, as also evidenced by CID experiments (Figure 1). This result suggests that either an isomerization reaction from 3_1 to 3_2 or a proton transfer from the ammonia to the hydroxido ligand should occur. Energetically, we can expect either one of the two processes to be favored with respect to the direct cleavage of acetic acid, which should be associated to a higher energy threshold. Calculations at the B3LYP/6‐311+G(d,p) (Pt=LanL2TZ) level were employed to evaluate the thermodynamic features of the dissociation process. Scheme 2 reports the calculated Gibbs energies at 298 K for the direct cleavage of either water (A) or acetic acid (B) starting from the isomers of the [3+H]+ complex that are protonated on either of the axial ligands involved in the neutral loss upon CID, i. e. 3_2 and 3_1, respectively.

Scheme 2.

Scheme 2

Schematic representation of the direct cleavage of A) water and B) acetic acid from isomers of [3+H]+ from either the protonated hydroxido ligand (3_2) or the protonated acetato ligand (3_1), path A and B, respectively. Relative Gibbs energies of the isomers are reported in parentheses, while the dissociation energy for each process is reported on top of the arrows. All Gibbs energies at 298 K are in kJ mol−1.

The dissociation of water from 3_2 is calculated to be less endoergonic than the cleavage of acetic acid from 3_1, in agreement with the fact that acetic acid fragmentation is not observed in the first dissociation event (see Figure 1 and Figure S1). At the same time, 3_2 is higher in energy than 3_1 and IR ion spectroscopy has determined its absence from the ionic population, therefore it is necessary to evaluate the energy required for isomer interconversion. Alternatively, one can hypotesize a proton transfer from ammonia to the axial hydroxido ligand as possible mechanism for water loss from 3_1.

Employing DFT at the B3LYP level, calculations of the energy profile involved in the two mechanisms has been evaluated. The blue profile in Figure 5 shows the PES for the dissociation reaction of water from 3_1 that involves a preliminary proton transfer from the ammonia ligand. The activation threshold is given by the energy of the transition state involved in the transfer of the proton from ammonia (3_1_TS) lying at 94.8 kJ mol−1 with respect to 3_1. The reaction proceeds via the intermediate characterized by protonation on the hydroxo group (3_3, 81.4 kJ mol−1) followed by a direct cleavage of water from this species accompanied by a change in the overall geometry of the remaining complex 3_3−w as shown in Figure 6.

Figure 6.

Figure 6

PESs for the water dissociation reaction from 3_1. The blue profile represents the reaction involving proton transfer from the ammonia ligand, while the green profile the isomerization reaction in which the proton is transferred from the carboxilato to the hydroxido ligand through the chlorido. Optimized structures at the B3LYP level are shown together with relative Gibbs energies at 298 K in kJ mol−1.

For the isomerization reaction (green profile, Figure 6), we were unable to locate the transition states corresponding to the proton transfer from the acetate group to the chloride and from the chloride to the hydroxido group. Nevertheless, the first step ultimately results in the intermediate structure 3_6, as shown in Figure 6, which lies at 121.3 kJ mol−1. This energy is significantly higher than the activation energy calculated for the proton transfer reaction involving the ammonia ligand (94.8 kJ mol−1), indicating that this isomerization mechanism likely plays a negligible role in the water dissociation reaction.

Interestingly, the product resulting from the direct cleavage of water from 3_2, denoted as 3_2−w in Figure 6 and exhibiting a square‐based pyramidal geometry, is higher in energy than its protomer 3_3−w, in which the NH₂ group is displaced from the equatorial plane.

The activation energy for the proton transfer leading to water dissociation (94.8 kJ mol−1) was compared to that for the direct cleavage of acetic acid from 3_1 (111.8 kJ mol−1). The absence of CH₃COOH neutral loss in the fragmentation pattern of [3+H]+ under either CID or IRMPD conditions is well supported by these calculations, which show that water loss is energetically favored.

A similar analysis applies to [4+H]+, where two protomers, 4_1 (protonated on the free carboxylate oxygen of the cyclobutane‐1,1‐dicarboxylate) and 4_3 (protonated on the axial hydroxido ligand), may contribute to the gas‐phase population. Notably, IRMPD bands characteristic of either isomer show the same dissociation path, leading to loss of water. Also in this case we can assume that dissociation occurs after a proton transfer from the ammonia molecule, generating the intermediate isomer 4_4, endowed with an even lower relative Gibbs energy when compared to 3_3, i. e. 30.6 and 80.2 kJ mol−1 at the B2PLYP level, respectively.

Conclusions

Collision‐induced dissociation (CID) experiments on various protonated Pt(IV) complexes with antineoplastic activity have demonstrated that when at least one axial hydroxido ligand is present, water dissociation becomes the primary fragmentation pathway. However, structural characterization of the complexes [3+H]+ and [4+H]+ has revealed a significant portion of the gas‐phase population corresponds to isomers protonated on the carboxylato moieties located in either axial or equatorial positions, respectively.

Calculations indicate that water dissociation occurs following a preliminary proton transfer from the ammonia ligand. This mechanism is further supported by the analysis of [1+H]+, a symmetric complex featuring two hydroxido ligands. In [1+H]+, the proton transfer activates IR bands associated with a high‐energy isomer possessing two aqua ligands in the axial positions.

Given the critical role of prototropic equilibria in influencing the activity of platinum‐containing drugs, it could be relevant to determine how charges are distributed among the axial and equatorial ligands. Notably, Pt(IV) complexes are being investigated as potential orally available alternatives to cisplatin and related compounds. Upon oral administration, these complexes would encounter the acidic environment of the stomach, where hydrolysis of both axial and equatorial ligands could be accelerated, potentially interfering with the intended activation mechanism which involves reduction within cancer cells.[ 31 , 32 , 33 , 35 , 36 ]

These results contribute to the understanding of protonation equilibria and ligand‐specific reactivity of Pt(IV) complexes. We hope these insights may aid in the design of platinum complexes with antineoplastic activity by clarifying their likely forms in acidic environments.

Conflict of Interests

The authors declare no conflict of interest.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Acknowledgments

This research was financially supported by Sapienza Università di Roma (Progetti Medi di Ateneo 2023, RM123188F7509A0B). We acknowledge the CINECA ISCRA‐C initiative, for the availability of high‐performance computing resources and support (project IsCb9_IRCu2Nu). Open Access publishing facilitated by Università degli Studi di Roma La Sapienza, as part of the Wiley ‐ CRUI‐CARE agreement.

Corinti D., Gabano E., Chiavarino B., Crestoni M. E., Osella D., Fornarini S., ChemPlusChem 2025, e202400754. 10.1002/cplu.202400754

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. Cohen S. M., Lippard S. J., Prog. Nucleic Acid Res. Mol. Biol. 2001, 67, 93–130. [DOI] [PubMed] [Google Scholar]
  • 2. Reedijk J., Pure Appl. Chem. 1987, 59, 181–192. [Google Scholar]
  • 3.B. Lippert, Cisplatin, Wiley, 1999.
  • 4. Wong E., Giandomenico C. M., Chem. Rev. 1999, 99, 2451–2466. [DOI] [PubMed] [Google Scholar]
  • 5. Dasari S., Bernard Tchounwou P., Eur. J. Pharmacol. 2014, 740, 364–378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Corinti D., Coletti C., Re N., Piccirillo S., Giampà M., Crestoni M. E., Fornarini S., RSC Adv. 2017, 7, 15877–15884. [Google Scholar]
  • 7. Jamieson E. R., Lippard S. J., Chem. Rev. 1999, 99, 2467–2498. [DOI] [PubMed] [Google Scholar]
  • 8. Marchán V., Moreno V., Pedroso E., Grandas A., Chem. Eur. J. 2001, 7, 808–815. [DOI] [PubMed] [Google Scholar]
  • 9. Johnstone T. C., Suntharalingam K., Lippard S. J., Chem. Rev. 2016, 116, 3436–3486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Gibson D., Dalt. Trans. 2009, 10681–10689. [DOI] [PubMed] [Google Scholar]
  • 11. Gibson D., Dalt. Trans. 2016, 45, 12983–12991. [DOI] [PubMed] [Google Scholar]
  • 12. Ravera M., Gabano E., McGlinchey M. J., Osella D., Dalt. Trans. 2022, 51, 2121–2134. [DOI] [PubMed] [Google Scholar]
  • 13. Shi H., Clarkson G. J., Sadler P. J., Inorg. Chem. Front. 2024, 11, 7898–7909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Hall M. D., Hambley T. W., Coord. Chem. Rev. 2002, 232, 49–67. [Google Scholar]
  • 15. Wexselblatt E., Gibson D., J. Inorg. Biochem. 2012, 117, 220–229. [DOI] [PubMed] [Google Scholar]
  • 16. Choi S., Filotto C., Bisanzo M., Delaney S., Lagasee D., Whitworth J. L. J. L., Jusko A., Li C., Wood N. A. N. A., Willingham J., Schwenker A., Spaulding K., Inorg. Chem. 1998, 37, 2500–2504. [Google Scholar]
  • 17. Tolbatov I., Coletti C., Marrone A., Re N., Inorg. Chem. 2018, 57, 3411–3419. [DOI] [PubMed] [Google Scholar]
  • 18. Ponte F., Scoditti S., Mazzone G., Sicilia E., Phys. Chem. Chem. Phys. 2023, 25, 15586–15599. [DOI] [PubMed] [Google Scholar]
  • 19. Dabbish E., Ponte F., Russo N., Sicilia E., Inorg. Chem. 2019, 58, 3851–3860. [DOI] [PubMed] [Google Scholar]
  • 20. Jovanović S., Petrović B., Bugarčić Ž. D., van Eldik R., Dalt. Trans. 2013, 42, 8890–8896. [DOI] [PubMed] [Google Scholar]
  • 21. Dong J., Huo S., Shen S., Xu J., Shi T., Elding L. I., Bioorg. Med. Chem. Lett. 2016, 26, 4261–4266. [DOI] [PubMed] [Google Scholar]
  • 22. Lemma K., Berglund J., Farrell N., Elding L. I., J. Biol. Inorg. Chem. 2000, 5, 300–306. [DOI] [PubMed] [Google Scholar]
  • 23. Lemma K., Sargeson A. M., Elding L. I., J. Chem. Soc. Dalt. Trans. 2000, 7, 1167–1172. [Google Scholar]
  • 24. Liu Y., Tian H., Xu L., Zhou L., Wang J., Xu B., Liu C., Elding L. I., Shi T., Int. J. Mol. Sci. 2019, 20, 5660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Corinti D., Crestoni M. E., Fornarini S., Dabbish E., Sicilia E., Gabano E., Perin E., Osella D., J. Biol. Inorg. Chem. 2020, 25, 655–670. [DOI] [PubMed] [Google Scholar]
  • 26. Bradáč O., Zimmermann T., Burda J. V., J. Mol. Model. 2013, 19, 4669–4680. [DOI] [PubMed] [Google Scholar]
  • 27. Ritacco I., Al Assy M., Abd El-Rahman M. K., Fahmy S. A., Russo N., Shoeib T., Sicilia E., Ashraf Fahmy S., Russo N., Shoeib T., Sicilia E., Inorg. Chem. 2017, 56, 6013–6026. [DOI] [PubMed] [Google Scholar]
  • 28. Zhao J., Xu Z., Lin J., Gou S., Inorg. Chem. 2017, 56, 9851–9859. [DOI] [PubMed] [Google Scholar]
  • 29. Wexselblatt E., Yavin E., Gibson D., Angew. Chemie - Int. Ed. 2013, 52, 6059–6062. [DOI] [PubMed] [Google Scholar]
  • 30. Wexselblatt E., Raveendran R., Salameh S., Friedman-Ezra A., Yavin E., Gibson D., Chem. - A Eur. J. 2015, 21, 3108–3114. [DOI] [PubMed] [Google Scholar]
  • 31. Wexselblatt E., Yavin E., Gibson D., Angew. Chemie Int. Ed. 2013, 52, 6059–6062. [DOI] [PubMed] [Google Scholar]
  • 32. Zhao J., Xu Z., Lin J., Gou S., Inorg Chem 2017, 56, 9851–9859. [DOI] [PubMed] [Google Scholar]
  • 33. Kastner A., Poetsch I., Mayr J., Burda J. V., Roller A., Heffeter P., Keppler B. K., Kowol C. R., Angew. Chemie Int. Ed. 2019, 58, 7464–7469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Ravera M., Gabano E., Zanellato I., Rangone B., Perin E., Ferrari B., Bottone M. G., Osella D., Dalt. Trans. 2021, 50, 3161–3177. [DOI] [PubMed] [Google Scholar]
  • 35. Gabano E., Ravera M., Perin E., Zanellato I., Rangone B., McGlinchey M. J., Osella D., Dalt. Trans. 2019, 48, 435–445. [DOI] [PubMed] [Google Scholar]
  • 36. Gabano E., Zanellato I., Pinton G., Moro L., Ravera M., Osella D., Bioinorg. Chem. Appl. 2022, 2022, 3698391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Xu Z., Tang W. K., Zhou Q., Chen S., Siu C.-K., Zhu G., Inorg. Chem. Front. 2021, 8, 3794–3802. [Google Scholar]
  • 38.N. C. Polfer, P. Dugourd, Laser Photodissociation and Spectroscopy of Mass-Separated Biomolecular Ions, Springer International Publishing, Cham, 2013.
  • 39. Martens J., van Outersterp R. E., Vreeken R. J., Cuyckens F., Coene K. L. M., Engelke U. F., Kluijtmans L. A. J., Wevers R. A., Buydens L. M. C., Redlich B., Berden G., Oomens J., Anal. Chim. Acta 2020, 1093, 1–15. [DOI] [PubMed] [Google Scholar]
  • 40. Lemaire J., Boissel P., Heninger M., Mauclaire G., Bellec G., Mestdagh H., Simon A., Le Caer S., Ortega J. M., Glotin F., Maitre P., Le Caer S., Ortega J. M., Glotin F., Maitre P., Phys. Rev. Lett. 2002, 89, 273001–273002. [DOI] [PubMed] [Google Scholar]
  • 41. Stedwell C. N., Galindo J. F., Roitberg A. E., Polfer N. C., Annu. Rev. Anal. Chem. 2013, 6, 267–285. [DOI] [PubMed] [Google Scholar]
  • 42. Carlo M. J., Patrick A. L., J. Mass Spectrom. Adv. Clin. Lab 2022, 23, 14–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Chiavarino B., Rotari L., Crestoni M. E., Corinti D., Fornarini S., Scuderi D., Salpin J.-Y., Inorg. Chem. 2023, 62, 14546–14558. [DOI] [PubMed] [Google Scholar]
  • 44. Corinti D., Paciotti R., Re N., Coletti C., Chiavarino B., Crestoni M. E., Fornarini S., Pure Appl. Chem. 2020, 92, 3–13. [Google Scholar]
  • 45. Cucchiaro A., Corinti D., Berden G., Oomens J., Elisa M., Cziferszky M., Inorg. Chim. Acta 2024, 569, 122158. [Google Scholar]
  • 46. He C. C., Hamlow L. A., Roy H. A., Devereaux Z. J., Hasan M. A., Israel E., Cunningham N. A., Martens J., Berden G., Oomens J., Rodgers M. T., J. Phys. Chem. B 2022, 126, 9246–9260. [DOI] [PubMed] [Google Scholar]
  • 47. He C. C., Hamlow L. A., Kimutai B., Roy H. A., Devereaux Z. J., Cunningham N. A., Martens J., Berden G., Oomens J., Chow C. S., Rodgers M. T., Phys. Chem. Chem. Phys. 2021, 23, 21959–21971. [DOI] [PubMed] [Google Scholar]
  • 48. Wheeler O. W., Salem M., Gao A., Bakker J. M., Armentrout P. B., J. Phys. Chem. A 2016, 120, 6216–6227. [DOI] [PubMed] [Google Scholar]
  • 49. Wensink F. J., Roos N., Bakker J. M., Armentrout P. B., Inorg. Chem. 2022, 61, 11252–11260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Roithová J., Bakker J. M., Mass Spectrom. Rev. 2022, 41, 513–528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Gramatica P., Papa E., Luini M., Monti E., Gariboldi M. B., Ravera M., Gabano E., Gaviglio L., Osella D., J. Biol. Inorg. Chem. 2010, 15, 1157–1169. [DOI] [PubMed] [Google Scholar]
  • 52. Varbanov H. P., Valiahdi S. M., Kowol C. R., Jakupec M. A., Galanski M., Keppler B. K., Dalt. Trans. 2012, 41, 14404. [DOI] [PubMed] [Google Scholar]
  • 53. Zanellato I., Bonarrigo I., Colangelo D., Gabano E., Ravera M., Alessio M., Osella D., J. Inorg. Biochem. 2014, 140, 219–227. [DOI] [PubMed] [Google Scholar]
  • 54. Ravera M., Gabano E., Zanellato I., Fregonese F., Pelosi G., Platts J. A., Osella D., Dalt. Trans. 2016, 45, 5300–5309. [DOI] [PubMed] [Google Scholar]
  • 55. Ravera M., Gabano E., Tinello S., Zanellato I., Osella D., J. Inorg. Biochem. 2017, 167, 27–35. [DOI] [PubMed] [Google Scholar]
  • 56. Sinha R. K., Maître P., Piccirillo S., Chiavarino B., Crestoni M. E., Fornarini S., Phys. Chem. Chem. Phys. 2010, 12, 9794–9800. [DOI] [PubMed] [Google Scholar]
  • 57. Prell J. S., O'Brien J. T., Williams E. R., J. Am. Soc. Mass Spectrom. 2010, 21, 800–809. [DOI] [PubMed] [Google Scholar]
  • 58. Grimme S., Antony J., Ehrlich S., Krieg H., J. Chem. Phys. 2010, 132, DOI 10.1063/1.3382344. [DOI] [PubMed] [Google Scholar]
  • 59. Barone V., Biczysko M., Bloino J., Phys. Chem. Chem. Phys. 2014, 16, 1759–1787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Schwabe T., Grimme S., Phys. Chem. Chem. Phys. 2007, 9, 3397–3406. [DOI] [PubMed] [Google Scholar]
  • 61. He C. C., Kimutai B., Bao X., Hamlow L., Zhu Y., Strobehn S. F., Gao J., Berden G., Oomens J., Chow C. S., Rodgers M. T., J. Phys. Chem. A 2015, 119, 10980–10987. [DOI] [PubMed] [Google Scholar]
  • 62. Cucchiaro A., Scherfler A., Corinti D., Berden G., Oomens J., Wurst K., Gust R., Crestoni M. E., Kircher B., Cziferszky M., J. Med. Chem. 2023, 66, 15256–15268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, G. A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. V. Marenich, J. Bloino, B. G. Janesko, R. Gomperts, B. Mennucci, H. P. Hratchian, J. V. Ortiz, A. F. Izmaylov, J. L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V. G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J. A. Montgomery, Jr., J. E. Peralta, F. Ogliaro, M. J. Bearpark, J. J. Heyd, E. N. Brothers, K. N. Kudin, V. N. Staroverov, T. A. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. P. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, J. M. Millam, M. Klene, C. Adamo, R. Cammi, J. W. Ochterski, R. L. Martin, K. Morokuma, O. Farkas, J. B. Foresman, and D. J. Fox, Gaussian 16, Revision C.01, Gaussian, Inc., Wallingford CT, 2016.
  • 64. Ritacco I., Al Assy M., Abd El-Rahman M. K., Fahmy S. A., Russo N., Shoeib T., Sicilia E., Ashraf Fahmy S., Russo N., Shoeib T., Sicilia E., Inorg. Chem. 2017, 56, 6013–6026. [DOI] [PubMed] [Google Scholar]
  • 65. Corinti D., Frison G., Chiavarino B., Gabano E., Osella D., Crestoni M. E., Fornarini S., Angew. Chemie Int. Ed. 2020, 59, 15595–15598. [DOI] [PubMed] [Google Scholar]
  • 66. Corinti D., Crestoni M. E., Fornarini S., Ponte F., Russo N., Sicilia E., Gabano E., Osella D., J. Am. Soc. Mass Spectrom. 2019, 30, 1881–1894. [DOI] [PubMed] [Google Scholar]
  • 67. Hunter E. P. L., Lias S. G., J. Phys. Chem. Ref. Data 1998, 27, 413–656. [Google Scholar]
  • 68. Corinti D., Berden G., Oomens J., Martinez-Haya B., Fornarini S., Crestoni M. E., Int. J. Mass Spectrom. 2024, 505, 117322. [Google Scholar]
  • 69. Polfer N. C., Chem. Soc. Rev. 2011, 40, 2211–2221. [DOI] [PubMed] [Google Scholar]
  • 70. Paciotti R., Corinti D., Coletti C., Re N., Berden G., Oomens J., Fornarini S., Crestoni M. E., Inorg. Chem. Front. 2024, 11, 8464–8478. [Google Scholar]
  • 71. Corinti D., De Petris A., Coletti C., Re N., Chiavarino B., Crestoni M. E., Fornarini S., ChemPhysChem 2017, 18, 318–325. [DOI] [PubMed] [Google Scholar]
  • 72. Patrick A. L., Cismesia A. P., Tesler L. F., Polfer N. C., Int. J. Mass Spectrom. 2017, 418, 148–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Martínez-Haya B., Avilés-Moreno J. R., Gámez F., Martens J., Oomens J., Berden G., Phys. Chem. Chem. Phys. 2024, 26, 198–208. [DOI] [PubMed] [Google Scholar]
  • 74. Martínez-Haya B., Avilés-Moreno J. R., Gámez F., Martens J., Oomens J., Berden G., J. Phys. Chem. Lett. 2023, 14, 1294–1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Yacovitch T. I., Heine N., Brieger C., Wende T., Hock C., Neumark D. M., Asmis K. R., J. Phys. Chem. A 2013, 117, 7081–7090. [DOI] [PubMed] [Google Scholar]
  • 76. Heine N., Yacovitch T. I., Schubert F., Brieger C., Neumark D. M., Asmis K. R., J. Phys. Chem. A 2014, 118, 7613–7622. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Chempluschem are provided here courtesy of Wiley

RESOURCES